A Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE) (BLISS-52)

计划入组 0 人

A Pooled Analysis of the HGS1006-C1056 (BLISS-52) and HGS1006-C1057 (BLISS-76) Studies

计划入组 1 人 · 首次发布于 2013 年 5 月 21 日

Effectiveness of Belimumab Treatment in a Subpopulation of Systemic Lupus Erythematosus (SLE) Patients: a Pooled Analysis of BLISS-52 and BLISS-76

计划入组 1,016 人 · 首次发布于 2013 年 8 月 2 日

Spinal Bliss

FLZ-52

ITM-52

BLISS GVS PHARMA LIMITED

India

52 North Health Ltd.

United Kingdom

Bliss Biopharmaceutical (Hangzhou) Co., Ltd.

China

Belimumab Shows Superior Efficacy for Systemic Lupus Erythematosus in Meta-Analysis

Belimumab Shows Superior Outcomes in Pediatric Lupus Nephritis Treatment Study

High Placebo Response Rates Challenge Lupus Drug Development as Researchers Develop New Trial Strategies